SCHEMBL13778201

SCHEMBL13778201

CN1CCN(c2ccc(-c3nc4c(C(=O)NC5CC6CCC5C6)ccnc4[nH]3)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.44
CSF1R P07333 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
CDK4 P11802 2/20 0.39
CCND1 P24385 1/20 0.39
CCND2 P30279 1/20 0.39
CCND3 P30281 1/20 0.39
AURKA O14965 2/20 0.38
PARP1 P09874 3/20 0.38
TNKS O95271 2/20 0.38
TNKS2 Q9H2K2 2/20 0.38
JAK2 O60674 2/20 0.38
ALK Q9UM73 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4145972 0.88 PARP1 (0.40) PARP1TNKSTNKS2JAK2ALK
SCHEMBL13778187 0.85 HTR3A (0.43)
SCHEMBL8234375 0.84 HSD17B10 (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2HSD17B10
SCHEMBL13778115 0.84 HSD17B10 (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2HSD17B10
SCHEMBL4161580 0.83 BMPR1B (0.47) HRH4MEN1KMT2APARP1TNKS
SCHEMBL4160457 0.83 BMPR1B (0.47) HRH4MEN1KMT2APARP1TNKS
SCHEMBL4153098 0.82 PARP1 (0.38) PARP1TNKSTNKS2JAK2ALK
SCHEMBL13778196 0.81 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ASMN1; SMN2HSD17B10
SCHEMBL13778204 0.80 ALDH1A1 (0.37) ALDH1A1MEN1KMT2ASMN1; SMN2HSD17B10
SCHEMBL4161139 0.80 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090170847-A1 Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same YUYU PHARMA, INC. (KR) 2009-07-02 US disclosed
US-20090170847-A1 Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same YUYU PHARMA, INC. (KR) 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170847-A1 Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same GSK3B, GSK3A, MAP3K3 HRH4 2026/4885CSF1R 1874/4885ALDH1A1 4274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.